PharmaLundensis AB (PHAL.ST)
- Previous Close
0.6000 - Open
0.5700 - Bid 0.5400 x --
- Ask 0.5720 x --
- Day's Range
0.5400 - 0.5880 - 52 Week Range
0.2900 - 1.5200 - Volume
50,480 - Avg. Volume
26,941 - Market Cap (intraday)
30.469M - Beta (5Y Monthly) -0.43
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PharmaLundensis AB operates as a pharmaceutical company. The company develops Iodocarb for treating chronic obstructive pulmonary disease; and treatments for chronic bronchitis and influenza-induced lung failure. It develops EcoFilter, a system that eliminates the release of pharmaceutical drugs and multi-resistant bacteria in hospital wastewater. PharmaLundensis AB was founded in 2006 and is based in Lund, Sweden.
www.pharmalundensis.seRecent News: PHAL.ST
View MorePerformance Overview: PHAL.ST
Trailing total returns as of 4/28/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PHAL.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PHAL.ST
View MoreValuation Measures
Market Cap
30.47M
Enterprise Value
34.92M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
9.68
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-19.47%
Return on Equity (ttm)
-119.23%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-3.85M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
1.27M
Total Debt/Equity (mrq)
173.41%
Levered Free Cash Flow (ttm)
-4.35M